If a patient is exposed to chickenpox, prophylaxis with varicella zoster immune globulin (VZIG) may be indicated.

See full prescribing information for complete boxed warningWhen treating patients with asthma, only prescribe ADVAIR DISKUS for patients not adequately controlled on a long-term asthma control medication, such as an inhaled corticosteroid, or whose disease severity clearly warrants initiation of treatment with both an inhaled corticosteroid and a LABA. In a single-dose crossover study, a higher-than-recommended dose of ADVAIR DISKUS was administered to 14 healthy adult subjects. You may need different treatment.What should I tell my healthcare provider before using ADVAIR DISKUS?Tell your healthcare provider about all of your health conditions, including if you:are allergic to any of the ingredients in ADVAIR DISKUS, any other medicines, or food products. In the two 1-year studies, ADVAIR DISKUS 250/50 was compared with salmeterol in 1,579 patients (863 males and 716 females).

No deaths were seen in rats given salmeterol at an inhalation dose of 2.9 mg/kg (approximately 240 and 110 times the MRHD for adults and children, respectively, on an mg/mADVAIR DISKUS 100/50, ADVAIR DISKUS 250/50, and ADVAIR DISKUS 500/50 are combinations of fluticasone propionate and salmeterol xinafoate.One active component of ADVAIR DISKUS is fluticasone propionate, a corticosteroid having the chemical name Fluticasone propionate is a white powder with a molecular weight of 500.6, and the empirical formula is CThe other active component of ADVAIR DISKUS is salmeterol xinafoate, a betaSalmeterol xinafoate is a white powder with a molecular weight of 603.8, and the empirical formula is CADVAIR DISKUS 100/50, ADVAIR DISKUS 250/50, and ADVAIR DISKUS 500/50 are specially designed plastic devices containing a double-foil blister strip of a powder formulation of fluticasone propionate and salmeterol xinafoate intended for oral inhalation only. You now have sucesfully register for the event and you can also access the latest updates, events and resources. While you are using ADVAIR DISKUS 2 times each day, do not use other medicines that contain a LABA for any reason.What are the possible side effects with ADVAIR DISKUS?ADVAIR DISKUS can cause serious side effects, including:See “What is the most important information I should know about ADVAIR DISKUS?”sudden breathing problems immediately after inhaling your medicinereduced adrenal function (may result in loss of energy)changes in blood (sugar, potassium, certain types of white blood cells)weakened immune system and a higher chance of infectionsYou will breathe in (inhale) the medicine from the DISKUSThe “Use by” date is 1 month from date of opening the pouch.To avoid releasing or wasting doses once the DISKUS is ready: Remember, never breathe out into the DISKUS mouthpiece.This Medication Guide has been approved by the U.S. Food and Drug Administration. To view updated drug label links, paste the RSS feed address (URL) shown below into a RSS reader, or use a browser which supports RSS feeds, such as Safari for Mac OS X.If you no longer wish to have this DailyMed RSS service, simply delete the copied URL from your RSS Reader. ADVAIR DISKUS has not been studied in patients with acutely deteriorating asthma or COPD. In addition, because there is a natural increase in corticosteroid production during pregnancy, most women will require a lower exogenous corticosteroid dose and many will not need corticosteroid treatment during pregnancy.New Zealand White rabbits were less sensitive since only delayed ossification of the frontal cranial bones was seen at an oral dose approximately 1,600 times the MRHD on an mg/mThere are no well-controlled human studies that have investigated effects of ADVAIR DISKUS on preterm labor or labor at term. The probability of a fracture over 3 years was 6.3% for ADVAIR DISKUS, 5.4% for fluticasone propionate, 5.1% for salmeterol, and 5.1% for placebo. During this period of HPA suppression, patients may exhibit signs and symptoms of adrenal insufficiency when exposed to trauma, surgery, or infection (particularly gastroenteritis) or other conditions associated with severe electrolyte loss.